TG Therapeutics Inc (TGTX)
16.31
-0.58
(-3.43%)
USD |
NASDAQ |
May 31, 16:00
16.29
-0.02
(-0.12%)
After-Hours: 20:00
TG Therapeutics Accounts Receivable (Quarterly): 64.98M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 64.98M |
December 31, 2023 | 51.09M |
September 30, 2023 | 39.32M |
June 30, 2023 | 17.48M |
March 31, 2023 | 8.623M |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.088M |
March 31, 2022 | 0.903M |
December 31, 2021 | 1.389M |
September 30, 2021 | 1.384M |
June 30, 2021 | 0.931M |
March 31, 2021 | 0.771M |
December 31, 2020 | 0.00 |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
64.98M
Maximum
Mar 2024
13.35M
Average
1.158M
Median
Accounts Receivable (Quarterly) Benchmarks
Amicus Therapeutics Inc | 76.43M |
Alnylam Pharmaceuticals Inc | 321.38M |
Cytokinetics Inc | 0.834M |
Insmed Inc | 37.16M |
Madrigal Pharmaceuticals Inc | -- |